Tezepelumab Efficacy and Safety in Reducing Oral Corticosteroid Use in Adults with Oral Corticosteroid Dependent Asthma

Trial Identifier: D5180C00024
Sponsor: AstraZeneca
Collaborator:
AMGEN
Start Date: August 2022
Primary Completion Date: March 2025
Study Completion Date: March 2025
Condition: Asthma

Available Languages

For questions about your Trial Results Summary, please see Sponsor contact section within your Trial Results Summary.

No documents have been posted yet.

Trial Locations